Study to Evaluate Efficacy & Safety of Tralokinumab in Subjects With Asthma Inadequately Controlled on Corticosteroids
Clinical trial NCT02449473 · COMPLETED
Trial details
- NCT number
- NCT02449473
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-29
- Primary completion
- 2017-06-21
- Enrollment
- 79
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.